A novel long noncoding RNA AC092718.4 as a prognostic biomarker and promotes lung adenocarcinoma progression
Figure 8.Correlation between various clinical features and overall survival in LUAD. (A–C) The prognosis of AC092718.4 is based on different subgroups, including stage, TNM stage, gender, residual tumor, smoker, age, and race.